If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,127.00    0.50 (0.04%)
Bid:
1,125.50
Ask:
1,126.50
Spread: 1.00 (0.089%)
Market Cap: £9.52b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Director/PDMR Shareholding

13 Aug 2025 17:08

RNS Number : 2390V
Smith & Nephew Plc
13 August 2025
 

SMITH & NEPHEW PLC

 

13 August 2025

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

1. VESTING OF SHARE AWARDS UNDER THE GLOBAL SHARE PLAN 2020

 

On 13 August 2025, the Company received notification of the following transactions in US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") following the vesting of awards under the Smith & Nephew Global Share Plan 2020.

 

All figures in these columns are stated to 6 decimal places where applicable.

 

 

PARTIAL VESTING OF 2023 CONDITIONAL AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020:

 

The awards were granted under the Global Share Plan 2020 on 11 August 2023. One third of the award vests in equal tranches over the following three years. A number of shares were sold to cover taxation obligations arising on the vesting of the awards.

 

The following relates to individuals included in the below notification:

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc ordinary shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Partial vesting on 12 August 2025 of Conditional Share awards granted on 11 August 2023 under the Smith & Nephew Global Share Plan 2020, and subsequent sale of shares to cover tax liability

Date of Transaction

2025 - 08 - 12

Place of Transaction

London Stock Exchange (XLON)

 

 

Name

(Position)

 

Status

Price (£)

Volume

Aggregated information

Rohit Kashyap

(President, Advanced Wound Management and Global

PDMR

13.571365

23,201 (of which 5,670 were sold and 17,531 were retained.)

N/A Single Transaction

 

 

 

Helen Barraclough

Company Secretary

Smith & Nephew plc

 

Tel: +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFIRTEIVLIE
Date   Source Headline
8th Mar 20181:15 pmRNSDirector/PDMR Shareholding
6th Mar 20182:59 pmRNSTransaction in Own Shares
5th Mar 20184:30 pmRNSAnnual Financial Report
1st Mar 201812:29 pmRNSDirectorate Change
1st Mar 201810:54 amRNSTotal Voting Rights
27th Feb 20183:55 pmRNSDirector/PDMR Shareholding
15th Feb 20185:43 pmRNSTransaction in Own Shares
14th Feb 20186:10 pmRNSTransaction in Own Shares
13th Feb 20184:11 pmRNSDirector/PDMR Shareholding
12th Feb 20189:15 amRNSTransaction in Own Shares
9th Feb 201812:20 pmRNSDirector/PDMR Shareholding
8th Feb 20184:49 pmRNSDirector/PDMR Shareholding
8th Feb 20187:00 amRNSFinal Results
7th Feb 20189:33 amRNSSmith & Nephew announces European launch of PICO 7
2nd Feb 201810:31 amRNSBlock listing Interim Review
1st Feb 20181:40 pmRNSTotal Voting Rights
31st Jan 20189:06 amRNSAppointment of Roland Diggelmann as Non-Exec. Dir.
23rd Jan 201812:00 pmRNSSmith & Nephew update on tax
9th Jan 20184:34 pmRNSDirector/PDMR Shareholding
4th Jan 20184:03 pmRNSDirector Declaration
2nd Jan 20182:33 pmRNSTotal Voting Rights
6th Dec 20172:19 pmRNSSmith & Nephew pilot digital wound care solution
6th Dec 20177:00 amRNSAcquisition of Rotation Medical Inc
1st Dec 20173:09 pmRNSTotal Voting Rights
22nd Nov 201710:25 amRNSDirector/PDMR Shareholding
15th Nov 20173:29 pmRNSTransaction in Own Shares
15th Nov 20178:00 amRNSNew RCT demonstrates effectiveness of ALLEVYN LIFE
13th Nov 20175:00 pmRNSDirector/PDMR Shareholding
13th Nov 20171:00 pmRNSLaunch of robotics-assisted knee replacement
13th Nov 20179:55 amRNSDirector/PDMR Shareholding
8th Nov 20176:03 pmRNSTransaction in Own Shares
8th Nov 201710:31 amRNSDirector/PDMR Shareholding
7th Nov 20175:47 pmRNSTransaction in Own Shares
6th Nov 20172:10 pmRNSTransaction in Own Shares
3rd Nov 20177:00 amRNSTrading Statement
2nd Nov 201712:13 pmRNSDirector/PDMR Shareholding
1st Nov 20171:55 pmRNSTotal Voting Rights
1st Nov 20171:43 pmRNSDirector/PDMR Shareholding
23rd Oct 20172:00 pmRNSAcquisition of tissue regeneration technology
19th Oct 201710:10 amRNSDividend Declaration
13th Oct 20179:00 amRNSNotice of Results
10th Oct 20174:21 pmRNSDirector/PDMR Shareholding
9th Oct 20177:00 amRNSRetirement of Chief Executive Officer by end 2018
4th Oct 20178:00 amRNSWound Expert Panel Report
2nd Oct 201710:24 amRNSTotal Voting Rights
2nd Oct 20179:00 amRNSDirectorate Change
18th Sep 20179:42 amRNSDirectorate Change
12th Sep 20174:45 pmRNSDirector/PDMR Shareholding
12th Sep 20172:18 pmRNSAdditional Listing
12th Sep 201711:30 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.